livehealth.store

NATCO Pharma recalls

NATCO Pharma has 2 recalls on record with the FDA and USDA, the earliest in 2024 and the latest reported on 17 Apr 2024. The most frequent reason is manufacturing (cgmp) deviations.

Total recalls2since 2024

Last 12 months0reported

Class I00% of total

Ongoing0latest 17 Apr 2024

Recalls per month, last 24 months

click a bar for that month

0Oct '24 0 0 0Jan '25 0 0 0Apr 0 0 0Jul 0 0 0Oct 0 0 0Jan '26 0 0 0Apr 0 0 0Jul 0 0

Severity split

Class I 0 0%Class II 2 100%Class III 0 0%

Why natco pharma is recalled

Manufacturing (CGMP) Deviations2100%

Product types

Stomach & Acid Reflux Medication2100%

By year

20242100%

All natco pharma recalls, newest first

2 total

Reported	Class	Recall	Company	Reason	Where
17 Apr 2024Drug	CLASS II	Lansoprazole Delayed-Release Capsules USP, 15 mg recalled	NATCO Pharma	Manufacturing (CGMP) Deviations	Nationwide
14 Feb 2024Drug	CLASS II	Lansoprazole Delayed-Release Capsules USP, 15 mg recalled	NATCO Pharma	Manufacturing (CGMP) Deviations	Nationwide

About this list

Records come from FDA enforcement reports and USDA FSIS notices, grouped by normalised name. A company operating under several names may appear more than once.